Cell Based Assays Drug Research Information 
Drug Target Review
JULY 7, 2025
The FDA’s new roadmap In April 2025, the FDA announced a major regulatory shift with its plan to phase out the requirement for animal testing in the development of monoclonal antibodies and other drugs, when scientifically appropriate.
DrugBank
FEBRUARY 12, 2025
CMap utilizes gene expression profiles to connect drugs, genes, and diseases, enabling researchers to identify potential repurposing candidates based on their transcriptional signatures. Key techniques include high-throughput screening (HTS), cell-based assays, and animal models.
Expert insights. Personalized for you.
52 
Let's personalize your content